Cargando…

Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis

BACKGROUND: Digital health programs assist patients with chronic obstructive pulmonary disease (COPD) to better manage their disease. Technological and adoption barriers have been perceived as a limitation. OBJECTIVE: The aim of the research was to evaluate a digital quality improvement pilot in Med...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jessica, Kaye, Leanne, Tuffli, Michael, Barrett, Meredith A, Jones-Ford, Shelanda, Shenouda, Tina, Gondalia, Rahul, Henderson, Kelly, Combs, Veronica, Van Sickle, David, Stempel, David A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010108/ https://www.ncbi.nlm.nih.gov/pubmed/31647471 http://dx.doi.org/10.2196/13286

Ejemplares similares

Impact of a digital health intervention on asthma resource utilization
por: Merchant, Rajan, et al.
Publicado: (2018)

Increased adherence to controller medication maintained during the COVID-19 pandemic
por: Theye, Benjamin, et al.
Publicado: (2021)

Concurrent Improvement Observed in Patient-Reported Burden and Sensor-Collected Medication Use Among Patients Enrolled in a COPD Digital Health Program
por: Kaye, Leanne, et al.
Publicado: (2021)

The relationship between objective app engagement and medication adherence in asthma and COPD: a retrospective analysis
por: Kaye, Leanne, et al.
Publicado: (2021)

Retrospective assessment of a collaborative digital asthma program for Medicaid-enrolled children in southwest Detroit: reductions in short-acting beta-agonist (SABA) medication use
por: Barrett, Meredith, et al.
Publicado: (2023)

Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic
por: Kaye, Leanne, et al.
Publicado: (2020)

Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma
por: Kaye, Leanne, et al.
Publicado: (2022)

Prediction of short-acting beta-agonist usage in patients with asthma using temporal-convolutional neural networks
por: Hirons, Nicholas, et al.
Publicado: (2023)

Perceptions of Environmental Influence and Environmental Information-Seeking Behavior Among People With Asthma and COPD
por: Parikh, Shivani, et al.
Publicado: (2022)

Digital Health Intervention for Asthma: Patient-Reported Value and Usability
por: Merchant, Rajan, et al.
Publicado: (2018)

The Adoption and Implementation of Digital Health Care in the Post–COVID-19 Era
por: Mosnaim, Giselle S., et al.
Publicado: (2020)

Feasibility of Deploying Inhaler Sensors to Identify the Impacts of Environmental Triggers and Built Environment Factors on Asthma Short-Acting Bronchodilator Use
por: Su, Jason G., et al.
Publicado: (2016)

Improved asthma outcomes observed in the vicinity of coal power plant retirement, retrofit, and conversion to natural gas
por: Casey, Joan A., et al.
Publicado: (2020)

The association between seasonal asthma exacerbations and viral respiratory infections in a pediatric population receiving inhaled corticosteroid therapy with or without long-acting beta-adrenoceptor agonist: A randomized study()
por: Prazma, Charlene M., et al.
Publicado: (2015)

Paradoxical Bronchoconstriction with Short-Acting Beta Agonist
por: Magee, Jared S., et al.
Publicado: (2018)

Changes in remote care adoption for asthma during the COVID-19 pandemic
por: Kaye, Leanne, et al.
Publicado: (2022)

Medication Adherence and Asthma Control with Once-Daily Indacaterol/Glycopyrronium/Mometasone Furoate Breezhaler Digital Companion: 90-Day Analysis from Germany
por: Woehrle, Holger, et al.
Publicado: (2023)

Long-Acting Beta Agonists Enhance Allergic Airway Disease
por: Knight, John M., et al.
Publicado: (2015)

Revisiting the Idea That Amyloid-β Peptide Acts as an Agonist for P2X7
por: Bibič, Lučka, et al.
Publicado: (2020)

The benefits of combined treatment with corticosteroids and long-acting beta agonists
por: Singh, Dave
Publicado: (2006)

Optimal Bronchodilation for COPD Patients: Are All Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonists the Same?
por: Miravitlles, Marc, et al.
Publicado: (2018)

Drosophila taste neurons as an agonist-screening platform for P2X receptors
por: Grimes, Leanne, et al.
Publicado: (2020)

Loss of Asthma Control in Pediatric Patients after Discontinuation of Long-Acting Beta-Agonists
por: R. O'Hagan, Adrian, et al.
Publicado: (2012)

Indacaterol: a new once daily long-acting beta(2) adrenoceptor agonist
por: Beeh, Kai M, et al.
Publicado: (2010)

Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
por: Rottenkolber, Marietta, et al.
Publicado: (2015)

Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
por: Dreher, Michael, et al.
Publicado: (2018)

Overuse of Short-Acting Beta-2 Agonists (SABAs) in Elite Athletes: Hypotheses to Explain It
por: Vertadier, Nicolas, et al.
Publicado: (2022)

Over-the-counter use of short-acting beta-2 agonists: a systematic review
por: Loh, Zhe Chi, et al.
Publicado: (2023)

Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists
por: Rebordosa, Cristina, et al.
Publicado: (2022)

Sensitivity of Lung Resistance and Compliance to Beta-Blocker Induced Bronchoconstriction and Long Acting Beta-Agonist Withdrawal in COPD
por: Jabbal, Sunny, et al.
Publicado: (2017)

Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial
por: Haney, Sarah, et al.
Publicado: (2005)

Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
por: Tashkin, Donald P, et al.
Publicado: (2010)

Genome‐wide association studies of exacerbations in children using long‐acting beta2‐agonists
por: Slob, Elise M. A., et al.
Publicado: (2021)

Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
por: Lee, Eung Gu, et al.
Publicado: (2023)

Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma–COPD overlap syndrome
por: Lee, Suh-Young, et al.
Publicado: (2016)

Factors Associated with Failure of Intermittent Nebulization with Short-Acting Beta-Agonists in Children with Severe Asthma Exacerbation
por: Kulalert, Prapasri, et al.
Publicado: (2020)

The Circadian Rhythm in Photosynthesis in Acetabularia in the Presence of Actinomycin D, Puromycin, and Chloramphenicol
por: Sweeney, Beatrice M., et al.
Publicado: (1967)

Understanding reliever overuse in patients purchasing over-the-counter short-acting beta(2) agonists: an Australian community pharmacy-based survey
por: Azzi, Elizabeth A, et al.
Publicado: (2019)

Metamaterial-enhanced near-field readout platform for passive microsensor tags
por: Wu, Ke, et al.
Publicado: (2022)

Effects of treatment with long-acting muscarinic antagonists (LAMA) and long-acting beta-agonists (LABA) on lung function improvement in patients with bronchiectasis: an observational study
por: Lee, Su Yeon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_705o1d1b5n3kbaqpua30codbqn